What is Travere Therapeutics, Inc. (TVTX)?
Travere Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases. The company's research and development efforts target conditions with significant unmet medical needs, particularly in the areas of nephrology and genetic disorders. Travere Therapeutics engages in clinical development programs to advance its pipeline of drug candidates through various stages of regulatory approval. The company collaborates with healthcare professionals, researchers, and patient communities to support its mission of addressing rare diseases. Its operations include regulatory affairs, manufacturing partnerships, and commercialization activities designed to bring therapies to market. Travere Therapeutics operates within the specialized pharmaceutical sector, navigating complex scientific, clinical, and regulatory environments to develop treatments for underserved patient populations.
Travere Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by trading dynamics in Travere Therapeutics, Inc., standing at $27.01. The price has varied between $26.11 and $27 during the day, changing by -0.2978%.
FAQ: Travere Therapeutics, Inc. (TVTX)
What is the current price of TVTX stock?
The latest trading price is $27.01.
Does TVTX pay dividends?
Dividends are not paid by the company.
Does TVTX have a formal corporate presence or regional headquarters in the UAE?
Travere Therapeutics, Inc. does not have an official presence or subsidiary in the UAE and operates via partners or distributors.
What is TVTX best known for?
Travere Therapeutics, Inc. is most famous for developing therapies for rare kidney diseases.
What assets are typically shown together with TVTX?
Commonly shown alongside TVTX: Seres Therapeutics Inc, SMG Swiss Marketplace Group AG, Lineage Inc
Latest shares articles



